The early formation and the variety of the tumor morphology, as well as the potent metastatic ability seen in the Ela-myc and MT-tgfα/Ela-myc transgenic mice, make them good animal models for testing new therapeutic and preventive regimens or agents for the management of pancreatic cancer. Here, TGFA is linked to neoplasm.